Navigation Links
New Cancer “Growth Blocking Super Drug” Patents Filed
Date:2/8/2013

San Diego, CA (PRWEB) February 08, 2013

The pharmaceutical world has been racing for the cure for cancer for decades with what most experts agree is limited success. The current drugs are either so toxic and damaging to the body that many patients have to weigh the benefits of their use or the drugs are only designed to treat specific types of cancers and often only specific “strains” of specific cancers.

There is now an emerging world class sprinter in the race to create the “Super Drug” – Kalos Therapeutics. The “Super Drug” in the cancer world refers to a drug that may be used to treat multiple types of cancer and their various strains while avoiding the additional trauma often caused by chemotherapy, radiation and many of the current cancer drugs.

Kalos Therapeutics is an emerging biomedical company with the exclusive patent to develop the ANP (Atrial Natriuretic Peptide) family of peptides as a new mechanism for the treatment of cancer.

Kalos is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.

George Colberg, the CEO of Kalos Therapeutics, has amassed a who’s who dream team representing the best and brightest of the cancer and bio-tech worlds. More importantly is the fact that the team has the ability to think differently about what is the most effective way to treat cancer. It is that difference in thinking that appears to be producing a game changing cancer therapy.

Anti-Cancer Bio-technology

“Kalos has successfully leveraged the natural antiproliferative activity of the Atrial Natriuretic Peptide (ANP) family of peptides in our pat
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
2. Transcreener Assays Highlighted for Challenging Microbial, Cancer and Epigenetic Drug Targets at SLAS 2013
3. Governor Cuomo Announces Continued Growth at Roswell Park Cancer Institute with Regional Economic Development Council Funding; RPCI Center for Personalized Medicine established with CTG (NASDAQ: CTGX) serving as its technology partner
4. Transition in cell type parallels treatment response, disease progression in breast cancer
5. Two University of Colorado Cancer Center Studies Show that Silibinin, Found in Milk Thistle, Protects Against UV-Induced Skin Cancer
6. Navigating Cancer Announces Jeff Oberlander as VP, Engineering
7. Tracking the Battle Against Breast Cancer With New Market Research
8. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
9. WaferGens MyDesign Open Platform Facilitates Rapid Development of a Proprietary Prostate Cancer Diagnostic Panel in the Lab of Dr. Arul Chinnaiyan at the University of Michigan Cancer Center
10. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
11. DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/11/2014)... (PRWEB) September 11, 2014 DuPont ... excited to announce that it has appointed ... two wholly owned subsidiaries, Essex Grain Products ... of Zemea® USP propanediol in the food and ... following USA eastern and mid-western states: Alabama, ...
(Date:9/11/2014)... Calif. and LONDON ... and Cancer Research Technology (CRT), the charity,s development ... Inc. (OTCBB: ASTY), a biotechnology company in the ... Asterias, novel immunotherapy treatment AST-VAC2 into clinical trials ... AST-VAC2 represents the tenth treatment to enter ...
(Date:9/11/2014)... 11, 2014 The Stem Cell Institute, ... seminar about umbilical cord stem cell therapy on Saturday, September ... Hill Country Resort from 1:00 pm to 4:00 pm. ... PhD – “Umbilical Cord Stem Cell Clinical Trials for ... is the founder of the Stem Cell Institute and Medistem ...
(Date:9/10/2014)... September 11, 2014 Rutgers University’s ... Innovations in Dermatological Sciences conference Oct. 8 in ... how the university, industry and government sectors can ... use. , This conference is unique in bringing ... collaboration, to share their successes, best-practices, and lessons ...
Breaking Biology Technology:DuPont Tate & Lyle Bio Products Appoints Skidmore Sales as Distributor for Zemea® USP 2DuPont Tate & Lyle Bio Products Appoints Skidmore Sales as Distributor for Zemea® USP 3Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 2Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 3Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 4Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 5Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 6Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 7Cancer Research UK, Cancer Research Technology And Asterias Biotherapeutics Partner To Trial Immunotherapy Vaccine For Lung Cancer 8Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014 2Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014 3Stem Cell Institute Public Seminar on Adult Stem Cell Therapy Clinical Trials in San Antonio, Texas September 20th, 2014 4Innovations in Dermatological Sciences 2014 2Innovations in Dermatological Sciences 2014 3
... Every surgical operation requires proper wound closure to ensure ... start-up business has received a $100,000 federal grant to ... Corp ., which develops tissue repair products and advanced ... Small Business Innovation Research grant. , ,The ...
... - With the U.S. economy showing alternating signs of ... to business organizations that might want to slow the ... a housing-induced recession. , ,The Information Technology and ... the Economic Benefits of the Information Technology Revolution, focused ...
... Evansville, Wis . - Gov. Jim Doyle may ... a 62,400-square-foot biodiesel plant that will be built here over ... made it possible. , ,The $60 million plant, to be ... fuel producer, will generate 45 million gallons of fuel per ...
Cached Biology Technology:Study affirms information technology-productivity link 2Study affirms information technology-productivity link 3Investors raise $25 million for biodiesel plant 2Investors raise $25 million for biodiesel plant 3
(Date:9/12/2014)... September 12, 2014 ... ) has announced the addition of the ... report to their offering. ,     (Logo: ... 2014 is a professional and in-depth study ... fingerprint lock industry. , ,The report provides ...
(Date:9/12/2014)... Research and Markets ( ... the  "Global Facial Recognition Market (2D Facial ... - Industry Analysis, Size, Share, Growth, Trends ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... was valued at USD 1.17 billion in ...
(Date:9/12/2014)... Sept. 12, 2014 Research and Markets ... IC Card Management System Industry Report 2014" report ... Card Management System Industry Report 2014 is a professional ... global IC card management system. The report ... classifications, applications and industry chain structure. The IC card ...
Breaking Biology News(10 mins):Global Fingerprint Lock Industry Report 2014 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 3Global IC Card Management System Industry Report 2014 2
... Obesity rates in the United States increased from 14.5% of ... 2009-2010. It,s believed that one contributing factor to expanding waistlines ... the ability to control energy intake may be affected by ... rate may impair the relationship between the sensory signals and ...
... the rapid and non-invasive characteristics and may ... Chunhua Chen and colleagues from Peking University, ... normobaric oxygen before focal cerebral ischemia, neurological ... reduced; the expression of hypoxia-inducible factor-1α, Notch-1, ...
... triangle depicting how many servings of each food group you ... MyPlate - the circle showing what a healthy meal looks ... Department of Agriculture (USDA) to help American consumers put the ... prompts us to think about what,s on our plate, illustrating ...
Cached Biology News:Slower-paced meal reduces hunger but affects calorie consumption differently 2Slower-paced meal reduces hunger but affects calorie consumption differently 3Who is using MyPlate? 2
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Synaptotagmin, phosphoSer309...
... Immunogen: ... region encompassing the human, mouse, ... Accession Number: ... Assurance: Routinely evaluated by ...
Goat polyclonal to PPP2R5D Immunogen: Peptide with sequence KRAEEFLTASQEAL, from C Terminus of the protein sequence according to NP_006236...
Biology Products: